Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

781 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical impact of [18F]FDG-PET/CT in ARI0002h treatment, a CAR-T against BCMA for relapsed/refractory multiple myeloma.
Zugasti I, Tormo-Ratera M, Oliver-Caldes A, Soler-Perromat JC, Gonzalez-Calle V, Moreno DF, Cabañas V, Lopez-Muñoz N, Bartolome-Solanas A, Español-Rego M, Reguera-Ortega JL, Rosiñol L, Lopez-Corral L, Tovar N, Rodríguez-Lobato LG, Alvarez Perez RM, Varea S, Olesti E, Gomez Grande A, Frutos L, Tamayo P, Juan M, Moraleda JM, Urbano-Ispizua Á, González-Navarro EAA, Martínez-López J, Mateos MV, Tomas X, Setoain X, Fernández de Larrea C. Zugasti I, et al. Among authors: mateos mv. Blood Adv. 2024 Nov 27:bloodadvances.2024014360. doi: 10.1182/bloodadvances.2024014360. Online ahead of print. Blood Adv. 2024. PMID: 39602341
Movement Behaviors and Bone Biomarkers in Young Pediatric Cancer Survivors: A Cross-Sectional Analysis of the iBoneFIT Project.
Gil-Cosano JJ, Ubago-Guisado E, Llorente-Cantarero FJ, Marmol-Perez A, Rodriguez-Solana A, Pascual-Gazquez JF, Mateos ME, Molina-Hurtado JR, Garcia-Fontana B, Narciso PH, Klentrou P, Gracia-Marco L. Gil-Cosano JJ, et al. Among authors: mateos me. Nutrients. 2024 Nov 16;16(22):3914. doi: 10.3390/nu16223914. Nutrients. 2024. PMID: 39599700 Free PMC article.
Clinical significance of complete remission and measurable residual disease in relapsed/refractory multiple myeloma patients treated with T-cell redirecting immunotherapy.
Zabaleta A, Puig N, Cedena MT, Oliver-Caldes A, Perez JJ, Moreno C, Tamariz-Amador LE, Rodriguez-Otero P, Prosper F, Gonzalez-Calle V, López-Corral L, Rey-Búa B, Puertas B, Mirás F, Sánchez-Pina JM, López-Muñoz N, Juan M, González-Navarro EA, Urbano Á, de Larrea CF, Blade J, Lahuerta JJ, Martinez-Lopez J, Mateos MV, San Miguel JF, Paiva B. Zabaleta A, et al. Among authors: mateos mv. Am J Hematol. 2024 Nov 16. doi: 10.1002/ajh.27526. Online ahead of print. Am J Hematol. 2024. PMID: 39548827
Comparison of the effectiveness of awake-prone positioning and high-flow nasal oxygen in patients with COVID-19-related acute respiratory failure between different waves.
Esperatti M, Olmos M, Busico M, Gallardo A, Vitali A, Quintana J, Kakisu H, Ferreyro BL, Fuentes NA; Argentine Collaborative Group on High Flow and Prone Positioning; Osatnik J, Saavedra SN, Matarrese A, Niquin GDR, Wasinger EG, Mast G, Andrada FJ, Lagazio AI, Romano NE, Laiz MM, Urrutia JG, Mogaadouro MA, Seifert MR, Mastroberti E, Moreno CN, Tirado AM, Viñas MC, Pintos JM, Gonzalez ME, Mateos M, Barbaresi V, Grimbeek AE, Stein L, Latronico AJ, Menéndez SL, Basualdo AD, Castrillo R. Esperatti M, et al. Among authors: mateos m. Crit Care Sci. 2024 Oct 21;36:e20240065en. doi: 10.62675/2965-2774.20240065-en. eCollection 2024. Crit Care Sci. 2024. PMID: 39442133 Free PMC article.
Immunoparesis recovery in newly diagnosed transplant ineligible multiple myeloma patients, an independent prognostic factor that complements minimal residual disease.
Lakhwani S, Mateos MV, Martínez-López J, Paiva B, Rosiñol Dachs L, Martínez R, Oriol A, Bargay J, González-Montes Y, Gironella M, Encinas C, Martín J, Jarque I, Granell M, Abella E, García-Mateo A, Hernández-Rivas JÁ, Ramila E, Krsnik I, Casado Montero LF, De Arriba F, Palomera L, Sampol A, Moraleda JM, Casanova M, Delgado P, Lafuente A, Amutio E, López-Martínez A, Altés A, Ruíz MÁ, Alegre A, Lopez-Anglada L, De La Cruz J, Alonso Fernández R, Bladé Creixenti J, Lahuerta JJ, San-Miguel J, Hernández MT. Lakhwani S, et al. Among authors: mateos mv. Ann Hematol. 2024 Oct 23. doi: 10.1007/s00277-024-06031-0. Online ahead of print. Ann Hematol. 2024. PMID: 39438321
Impact of COVID-19 on outcomes with teclistamab in patients with relapsed/refractory multiple myeloma in the phase 1/2 MajesTEC-1 study.
van de Donk NWCJ, Bahlis N, Costa LJ, Mateos MV, Nooka AK, Perrot A, Garfall AL, Thaman P, Qi K, Uhlar C, Chastain K, Doyle M, Usmani SZ. van de Donk NWCJ, et al. Among authors: mateos mv. Blood Cancer J. 2024 Oct 21;14(1):186. doi: 10.1038/s41408-024-01160-1. Blood Cancer J. 2024. PMID: 39433732 Free PMC article. No abstract available.
Minimally Invasive Assessment of Peripheral Residual Disease During Maintenance or Observation in Transplant-Eligible Patients With Multiple Myeloma.
Lasa M, Notarfranchi L, Agullo C, Gonzalez C, Castro S, Perez JJ, Burgos L, Guerrero C, Calasanz MJ, Flores-Montero J, Oriol A, Bargay J, Rios R, Cabañas V, Cabrera C, Martinez-Martinez R, Encinas C, De Arriba F, Hernandez MT, Palomera L, Orfao A, Martinez-Lopez J, Mateos MV, San-Miguel J, Lahuerta JJ, Rosiñol L, Blade J, Cedena MT, Puig N, Paiva B; PETHEMA/GEM Cooperative Group. Lasa M, et al. Among authors: mateos mv. J Clin Oncol. 2024 Oct 1:JCO2400635. doi: 10.1200/JCO.24.00635. Online ahead of print. J Clin Oncol. 2024. PMID: 39353166
781 results